Overview

Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the role of cetuximab (Erbitux) with chemotherapy for advanced colorectal carcinoma. This study will determine if this new agent can improve one's response to standard treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Fox Chase Cancer Center
Treatments:
Cetuximab